Search Page

1

Cite

Share

Renal Toxicities of Targeted Therapies.

Abbas A, Mirza MM, Ganti AK, Tendulkar K. Abbas A, et al. Among authors: ganti ak. Target Oncol. 2015 Dec;10(4):487-99. doi: 10.1007/s11523-015-0368-7. Target Oncol. 2015. PMID: 25922090 Review.

Cite

Share

2

Cite

Share

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.

Kalemkerian GP, Loo BW, Akerley W, Attia A, Bassetti M, Boumber Y, Decker R, Dobelbower MC, Dowlati A, Downey RJ, Florsheim C, Ganti AKP, Grecula JC, Gubens MA, Hann CL, Hayman JA, Heist RS, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran CA, Morgensztern D, Pokharel S, Portnoy DC, Rhodes D, Rusthoven C, Sands J, Santana-Davila R, Williams CC, Hoffmann KG, Hughes M. Kalemkerian GP, et al. Among authors: ganti akp. J Natl Compr Canc Netw. 2018 Oct;16(10):1171-1182. doi: 10.6004/jnccn.2018.0079. J Natl Compr Canc Netw. 2018. PMID: 30323087

Cite

Share

3

Cite

Share

The role of targeted therapy in thymic carcinoma.

Krishnan M, Ganti AK. Krishnan M, et al. Among authors: ganti ak. J Oncol Pharm Pract. 2019 Oct;25(7):1712-1718. doi: 10.1177/1078155219852758. Epub 2019 Jun 4. J Oncol Pharm Pract. 2019. PMID: 31159657 Review.

Cite

Share

4

Cite

Share

Family planning in adolescents.

Ganti AK, Hillard PJA. Ganti AK, et al. Curr Opin Obstet Gynecol. 2019 Dec;31(6):447-451. doi: 10.1097/GCO.0000000000000577. Curr Opin Obstet Gynecol. 2019. PMID: 31652151 Review.

Cite

Share

5

Cite

Share

Targeting the EGFR signaling pathway in cancer therapy.

Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Seshacharyulu P, et al. Among authors: ganti ak. Expert Opin Ther Targets. 2012 Jan;16(1):15-31. doi: 10.1517/14728222.2011.648617. Epub 2012 Jan 12. Expert Opin Ther Targets. 2012. PMID: 22239438 Free PMC article. Review.

Cite

Share

6

Cite

Share

Immunotherapy in lung cancer: the chemotherapy conundrum.

Buddharaju LNR, Ganti AK. Buddharaju LNR, et al. Among authors: ganti ak. Chin Clin Oncol. 2020 Aug;9(4):59. doi: 10.21037/cco.2020.01.05. Epub 2020 Feb 4. Chin Clin Oncol. 2020. PMID: 32036674 Free article. No abstract available.

Cite

Share

7

Cite

Share

Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer.

Islam KM, Anggondowati T, Deviany PE, Ryan JE, Fetrick A, Bagenda D, Copur MS, Tolentino A, Vaziri I, McKean HA, Dunder S, Gray JE, Huang C, Ganti AK. Islam KM, et al. Among authors: ganti ak. BMC Cancer. 2019 Aug 27;19(1):835. doi: 10.1186/s12885-019-6054-x. BMC Cancer. 2019. PMID: 31455252 Free PMC article.

Cite

Share

8

Cite

Share

Lung cancer-A global perspective.

McIntyre A, Ganti AK. McIntyre A, et al. Among authors: ganti ak. J Surg Oncol. 2017 Apr;115(5):550-554. doi: 10.1002/jso.24532. Epub 2017 Apr 18. J Surg Oncol. 2017. PMID: 28418583 Review.

Cite

Share

9

Cite

Share

Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.

Cinar P, Cox J, Kamal A, Bickel K, Krzyzanowska M, Armitage J, Ganti AK, Ward J, Wong S, Lonial S, Bosserman L. Cinar P, et al. Among authors: ganti ak. JCO Oncol Pract. 2020 Aug;16(8):431-434. doi: 10.1200/OP.20.00326. Epub 2020 May 28. JCO Oncol Pract. 2020. PMID: 32463764 No abstract available.

Cite

Share

10

Cite

Share

Pembrolizumab-the "KEY" to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC).

Yellala A, Ganti AK. Yellala A, et al. Among authors: ganti ak. Transl Lung Cancer Res. 2020 Jun;9(3):824-827. doi: 10.21037/tlcr.2020.04.12. Transl Lung Cancer Res. 2020. PMID: 32676346 Free PMC article. No abstract available.

Cite

Share